Invention Grant
- Patent Title: Biomarker test for prediction or early detection of preeclampsia and/or HELLP syndrome
-
Application No.: US14407516Application Date: 2013-06-13
-
Publication No.: US10670610B2Publication Date: 2020-06-02
- Inventor: Adi L. Tarca , Nandor Than , Gabor Juhasz , Adrienna Katalin Kekesi , Hamutal Meiri , Zoltan Papp , Roberto Romero
- Applicant: WAYNE STATE UNIVERSITY
- Applicant Address: US MI Detroit US MD Bethesda HU Budapest HU Pécs
- Assignee: Wayne State University,The United States of America as represented by The Secretary, Department of Health and Human Services Office of Technology Transfer, National Institutes of Health,Semmelweis University,Genesis Theranostix Korlatolt Felelossegu Tarsasag
- Current Assignee: Wayne State University,The United States of America as represented by The Secretary, Department of Health and Human Services Office of Technology Transfer, National Institutes of Health,Semmelweis University,Genesis Theranostix Korlatolt Felelossegu Tarsasag
- Current Assignee Address: US MI Detroit US MD Bethesda HU Budapest HU Pécs
- Agent Jason D. Voight
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@4d92f07c
- International Application: PCT/US2013/045709 WO 20130613
- International Announcement: WO2013/188686 WO 20131219
- Main IPC: G01N33/68
- IPC: G01N33/68 ; C12Q1/6883
Abstract:
Disclosed are specific biomarkers that allow for early testing of preeclampsia/HELLP syndrome. Thus, a method is provided predicting preeclampsia in a pregnant woman. Also disclosed is a kit comprising means for assaying a sample from a pregnant woman for the concentrations of the specific biomarkers.
Public/Granted literature
- US20160187347A1 BIOMARKER TEST FOR PREDICTION OR EARLY DETECTION OF PREECLAMPSIA AND/OR HELLP SYNDROME Public/Granted day:2016-06-30
Information query
IPC分类:
